𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…

✍ Scribed by Olivier Rosmorduc; Christèle Desbois-Mouthon

Book ID
116652543
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
470 KB
Volume
55
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib in Advanced Hepatocellular Car
Sorafenib in Advanced Hepatocellular Carcinoma
✍ Llovet, Josep M.; Ricci, Sergio; Mazzaferro, Vincenzo; Hilgard, Philip; Gane, Ed 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 331 KB
Development of sorafenib and other molec
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma
✍ Andrew X. Zhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

## Abstract It is well appreciated that hepatocellular carcinoma (HCC) represents one of the most challenging malignancies of worldwide importance. In fact, HCC is the fifth most common cancer and the third most common cause of cancer‐related death globally. The incidence rates for HCC in the U.S.